JOURNAL ARTICLE
Four Years of EGOI: Between Science and Clinical Practice on Inositols. Meeting Report ISGE 2024 – EGOI-PCOS Session.
Published In: Gynecologic & Obstetric Investigation, 2024, v. 89, n. 6. P. 520 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Pkhaladze, Lali; Kamenov, Zdravko; Nordio, Maurizio; Myers, Samuel H.; Unfer, Vittorio 3 of 3
Abstract
The document discusses the role of inositols in the treatment of polycystic ovary syndrome (PCOS) and highlights recent advancements in research and clinical practice. Inositols, particularly myo-inositol, have shown promise in improving metabolic parameters, reducing hyperandrogenism, and restoring ovulation in PCOS patients. The document also emphasizes the importance of personalized treatment approaches based on PCOS phenotypes and the potential synergistic effect of combining myo-inositol with α-lactalbumin to enhance therapeutic outcomes. The report aims to stimulate further research into the applications of inositols in PCOS treatment. [Extracted from the article]
Additional Information
- Source:Gynecologic & Obstetric Investigation. 2024/11, Vol. 89, Issue 6, p520
- Document Type:Article
- Subject Area:Complementary and Alternative Medicine
- Publication Date:2024
- ISSN:0378-7346
- DOI:10.1159/000541287
- Accession Number:181625873
- Copyright Statement:Copyright of Gynecologic & Obstetric Investigation is the property of Karger AG and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.